Sera Prognostics (SERA) Capital Expenditures (2020 - 2026)
Sera Prognostics (SERA) posted Capital Expenditures of $8000.0 for Q1 2026, down 97.58% on a QoQ basis from $330000.0 in Q4 2025, and up 166.67% year-over-year from $3000.0 in Q1 2025.
Sera Prognostics (SERA) Capital Expenditures (2020 - 2026) Analysis & Trends
Sera Prognostics' Capital Expenditures history runs 7 years deep, the most recent figure standing at $8000.0 for Q1 2026.
- Quarterly Capital Expenditures rose 166.67% year-over-year to $8000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $731000.0 (up 1561.36% YoY) and the FY2025 annual result came in at $726000.0, up 1196.43% from the prior year.
- Capital Expenditures was $8000.0 for Q1 2026 at Sera Prognostics, down from $330000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $372000.0 in Q3 2022 and bottomed at $3000.0 in Q1 2025.
- A 5-year average of $100529.4 and a median of $26000.0 in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures plunged 93.01% — and 2025, when it soared 4025.0%.
- Sera Prognostics' Capital Expenditures stood at $193000.0 in 2022, then slumped by 91.71% to $16000.0 in 2023, then plunged by 50.0% to $8000.0 in 2024, then surged by 4025.0% to $330000.0 in 2025, then tumbled by 97.58% to $8000.0 in 2026.
- Business Quant data shows SERA's Capital Expenditures at $8000.0 in Q1 2026, $330000.0 in Q4 2025, and $112000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 76.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 178.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -85.46 Mn |
| 10 | Sera Prognostics | 105.54 Mn | 105.54 Mn | -28,000.00 | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 330,000.00 |
| Dec 31, 2025 | 330,000.00 |
| Sep 30, 2025 | 112,000.00 |
| Sep 30, 2025 | 112,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Dec 31, 2023 | 16,000.00 |